Page 19 - ebook

고형암 항암치료 환자의 부작용 관리 Nausea and Vomiting

Classification Agent

Oral Low-moderate Abemaciclib
emetic risk Acalabrutinib
Afatinib
Alectinib
Alpelisib
Axitinib
Bexarotene
Brigatinib
Bosutinib ≤ 500 mg/day
Busulfan < 4 mg/day
Cabozantinib
Capecitabine
Chlorambucil
Cbimetinib
Cyclophosphamide < 100 mg/m /day
2
Dacomitinib
Dasatinib
Decitabine and cedazuridine
Duvelisib
Entrectinib
Erdafitinib
Erlotinib
Everolimus
Fludarabine
Gefitinib
Gilteritinib
Glasegib
Hydroxyurea
Ibrutinib
Idelaisib
Imatinib ≤ 400 mg/day
Ixazomib
Ovosidenib
Lapatinib
Larotrectinib
Lenalidomide
Levatinib ≤ 12 mg/day
Lorlatinib
Melphalan
Mercaptopurine
Methotrexate
Nilotinib
Neratinib
Osimertinib
Pabociclib
Panobinostat
Pazopanib

19